Stay updated with breaking news from Peer Exchange. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experts explore treatment considerations when treating patients with metastatic breast cancer with elacestrant, including dosing, patient selection, adherence, and treatment duration. Participants also discuss dose modifications, adherence concerns, and how they determine treatment failure.
Heather Landau, MD, invites panelists to provide their insights on the future outlook for the treatment of AL amyloidosis.
The criticality of patient education in BTKi use and its impact on treatment adherence is discussed.
Explore the facilitation of novel therapy access for desmoid tumors and discover emerging treatments reshaping the landscape.
Experts evaluate the financial impact experience by patients receiving BTK inhibitor therapy.